Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
LayerZero claims 91% transfer share, hits 6 month high – 2 risks could cap ZRO’s rally

LayerZero claims 91% transfer share, hits 6 month high – 2 risks could cap ZRO’s rally

AMBCryptoAMBCrypto2026/10/04 16:00

After falling to $1.70, LayerZero [ZRO] bounced back, defended $2, and climbed to a six-month high of $2.14. At press time, ZRO traded around $2.03, up 15% on the daily charts.

Why is LayerZero rallying now?

LayerZero rallied as its cross-chain activity drew renewed market attention.

@media only screen and (min-width: 0px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 50px; transition: min-height 0.3s ease; } } @media only screen and (min-width: 640px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 90px; } }
AD

That dominance followed a single-day record of $4 billion in transfers. However, one wallet did much of the heavy lifting.

The activity put LayerZero in the spotlight, although its concentration leaves a question: can broader usage sustain that momentum?

Are LayerZero’s large holders preparing to sell?

As LayerZero gained, exchange transfers from strategic partners and large holders followed.

Such movements can stir sell-off concerns, although transfers alone do not confirm sales. They could also serve custody or liquidity needs.

The wallet had received those tokens barely a day earlier. That quick turnaround raised questions about a potential sale.

Meanwhile, CoinGlass data showed that LayerZero’s Spot Netflow had remained positive for four consecutive days.

On the 3rd of October, Spot Netflow reached a recent high of $9.1 million. It remained positive at approximately $1.45 million at press time.

More tokens were entering exchanges than leaving, increasing the supply available for potential selling. Whether holders actually cash out could determine how much pressure the rally faces.

Can ZRO hold $2 and reach THIS?

LayerZero’s price structure remained bullish, with higher lows forming along rising support.

The Relative Strength Index (RSI) reinforced that momentum, climbing to approximately 79, inside overbought territory.

Buyers retained strong momentum, although an elevated RSI also leaves room for a pullback.

If buying persists, LayerZero could hold $2 and target $2.20, with $2.50 as a medium-term objective. However, exchange inflows could complicate that path if deposits translate into selling. A loss of $2 could bring the $1.70 support back into focus.

Final Summary

  • LayerZero rallied 15%, while one large WPAY transfer accounted for approximately 90% of its daily cross-chain transfer record.
  • ZRO’s bullish momentum faced growing exchange inflows, with $2 serving as the immediate level to hold.
News Image 0News Image 1News Image 2News Image 3
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy

Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.

智通财经•2026/10/12 23:31

BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.

智通财经•2026/10/12 23:27
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review

Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).

智通财经•2026/10/12 23:11